LFCR
Lifecore Biomedical Inc.
4.30$
-2.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.8% | 88.9% | 67.0% | 67.0% | 54.4% | 78.2% | 66.0% | 72.0% | 61.6% | 75.0% | 80.8% | 64.7% | 69.3% | |
| 32.2% | 11.1% | 33.0% | 33.0% | 45.6% | 21.8% | 34.0% | 28.0% | 38.4% | 25.0% | 19.2% | 35.3% | 30.7% | |
| 8.4% | 8.8% | 7.0% | 10.2% | 5.7% | 8.8% | 5.9% | 5.8% | 5.8% | 6.3% | 5.2% | 4.5% | 5.5% | |
| 41.3% | 37.5% | 31.0% | 45.8% | 32.3% | 57.9% | 34.1% | 28.7% | 24.6% | 28.6% | 34.1% | 23.3% | 27.0% | |
| 56.8% | 135.2% | 104.9% | 37.8% | 39.9% | 68.7% | 40.1% | 53.7% | 23.7% | 34.9% | 39.4% | 27.8% | 30.5% | |
| -24.6% | -35.2% | -4.9% | -4.8% | 5.7% | -46.9% | -6.0% | -25.7% | 14.6% | -9.9% | -20.1% | 7.5% | 0.1% | |
| 18.2% | 16.1% | 13.5% | 15.4% | 15.3% | 21.7% | 16.8% | 15.6% | 15.1% | 20.5% | 31.7% | 22.7% | 21.6% | |
| -42.4% | -51.1% | 47.0% | -114.8% | -18.9% | -65.8% | -20.0% | -42.0% | -3.1% | -31.0% | -64.4% | -18.0% | -25.5% | |
| 0.3% | – | – | 0.9% | -0.2% | -0.1% | 0.1% | 0.0% | 0.1% | 1.1% | 0.2% | 0.1% | 0.3% | |
| -137.6% | -43.9% | 47.2% | -139.4% | -18.7% | -65.7% | -20.2% | -42.0% | -3.1% | -32.1% | -64.6% | -18.0% | -25.8% | |
| -12.1% | – | – | -88.0% | 2.4% | -36.0% | 3.0% | -20.5% | 17.3% | -22.9% | -22.8% | 12.1% | -1.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.